Hamed Aissaoui

This inventor holds 38 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Orexin Receptor Modulators. Top assignees: Actelion Pharmaceuticals Ltd, Idorsia Pharmaceuticals Ltd, Other. Active years: 2004-2022.

USPTO Granted Patents = 38 (Patent Applications = 11)

% Patents Active = 23.7

CIPO Patents = 1

EPO Patents = 15 (Patent Applications = 11)

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 201(Granted Patents)

Location History:

Wittenheim, FR (2004 - 2007)
Purlversheim, FR (2008)
Pulversheim, FR (2006 - 2016)
Allschwil, CH (2013 - 2022)

Company Filing History:

31 out of 217

Actelion Pharmaceuticals Ltd

patents

6 out of 81

Idorsia Pharmaceuticals Ltd

patents

1 out of 834,453

Other

patents

Years Active: 2004-2022

Loading Chart...

Areas of Expertise:

Orexin Receptor Antagonists

NADPH Oxidase Inhibitors

Piperidine Derivatives

Prostaglandin D2 Modulators

Antimalarial Agents

Heterocyclic Compounds

Azaindole Derivatives

Lactam Derivatives

Quinoxaline Derivatives

Tetrahydroisoquinoline Derivatives

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11306078 - Piperidine CXCR7 receptor modulators (2022-04-19),

2. 11136317 - NADPH oxidase 4 inhibitors (2021-10-05),

3. 10752620 - Piperdine CXCR7 receptor modulators (2020-08-25),

4. 10584118 - NADPH oxidase 4 inhibitors (2020-03-10),

5. 10351560 - Crystalline forms (2019-07-16),

6. 10301309 - Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators (2019-05-28),

7. 9879006 - [object Object] (2018-01-30),

8. 9850241 - Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators (2017-12-26),

9. 9637473 - Acrylamide derivatives as antimalarial agents (2017-05-02),

10. 9255090 - Heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators (2016-02-09),

11. 9242970 - Lactam derivatives useful as orexin receptor antagonists (2016-01-26),

12. 9169270 - 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators (2015-10-27),

13. 9096595 - 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulators (2015-08-04),

14. 8889688 - Piperazines as antimalarial agents (2014-11-18),

15. 8697869 - 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators (2014-04-15),

Title: The Innovative Journey of Hamed Aissaoui

Introduction: Hamed Aissaoui, a talented inventor hailing from Pulversheim, France, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Hamed Aissaoui's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, and a sustainable energy solution that aims to reduce carbon emissions.

Career Highlights: With a background in engineering and a passion for innovation, Hamed Aissaoui has successfully brought several inventions from concept to reality, earning him recognition as a leading figure in the tech industry.

Collaborations: Throughout his career, Hamed Aissaoui has collaborated with top research institutions and tech companies to further develop his inventions and bring them to the market, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: Hamed Aissaoui's dedication to pushing the boundaries of technology and his commitment to creating solutions that improve our daily lives make him a true visionary in the world of innovation.